infectious disease

News

Brexit Health Alliance warns on infection threat

Boehringer takes on antimicrobial resistance with Evotec, bi...

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections.

News

Gilead tries again with twice-yearly HIV drug lenacapavir

Gilead Sciences has refiled for FDA approval of its HIV capsid inhibitor lenacapavir – which only needs to be dosed every six months – after the drug was rejected by the regulator in Februa

News

GSK hepatitis B hope bepirovirsen heads for phase 3 test

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a

News

Third FDA rejection for Verrica's molluscum contagiosum drug

Shares in US biotech Verrica Pharma lost half their value today after the FDA declined to approve its candidate treatment for viral skin infection molluscum contagiosum for a third time.

News

Monkeypox cases are rising. Should we be worried?

The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan Africa, with cases rising above the 100-mark a few days ago and the

News

Moderna's HIV vaccine prepped for trials in Africa

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.

Boehringer takes on antimicrobial resistance with Evotec, bi...

Gilead tries again with twice-yearly HIV drug lenacapavir

GSK hepatitis B hope bepirovirsen heads for phase 3 test

Third FDA rejection for Verrica's molluscum contagiosum drug

Monkeypox cases are rising. Should we be worried?

Moderna's HIV vaccine prepped for trials in Africa

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

infectious disease

Editor's Picks